<DOC>
	<DOCNO>NCT01223339</DOCNO>
	<brief_summary>This study characterize pharmacokinetics , safety , tolerability , pharmacodynamics single multiple oral dos ( SD , MD ) ertugliflozin ( PF-04971729 , MK-8835 ) Japanese healthy participant . The secondary objective investigate safety , tolerability , pharmacokinetics , pharmacodynamics single dos ertugliflozin Western healthy participant compare Japanese healthy participant .</brief_summary>
	<brief_title>Evaluation Pharmacokinetics , Safety , And Tolerability Of Ertugliflozin ( PF-04971729 , MK-8835 ) In Japanese And Western Healthy Participants ( MK-8835-041 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Healthy male and/or female subject nonchildbearing potential , age 18 55 year , inclusive Body Mass Index ( BMI ) 17.5 30.5 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) . Japanese subject must four Japanese grandparent born Japan . Mean body weight body weight range Western subject similar Japanese subject 10 % plus minus error . An informed consent document sign date subject . Subjects willing able comply schedule visit , treatment plan , laboratory test , study procedure . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease Asian Polynesian subject Western subject group . Any condition possibly affect drug absorption ( eg , gastrectomy ) . A positive urine drug screen . History regular alcohol consumption exceed 7 drinks/week female 14 drinks/week male within 6 month screen . History evidence habitual use tobacco nicotine containing product within 3 month Screening , exception light smoking ( 5 cigarette per day equivalent ) . Treatment investigational drug within 30 day 5 halflives precede first dose study medication . 12lead ECG demonstrate QTc &gt; 450 msec screening . Subjects ANY follow abnormality safety laboratory test ) : Evidence glycosuria , define positive urine dipstick test ; Fasting serum triglyceride &gt; 300 mg/dL ; Fasting LDLcholesterol &gt; equal 190 mg/dL . Fasting serum glucose &gt; 125 mg/dL .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Ertugliflozin</keyword>
	<keyword>Japanese Western population</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>pharmacodynamics</keyword>
</DOC>